Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
6
users have commented on this narrative
46
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
17
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Carter's
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Falling Birth Rates And Pricing Pressure Will Hurt Future Performance
Key Takeaways Declining birth rates and limited international growth constrain Carter's future revenue and earnings potential, keeping long-term demand and expansion prospects subdued. Intensifying competition from e-commerce and fast-fashion, plus cost pressures from tariffs and sustainability efforts, threaten Carter's profit margins and increase earnings volatility.
View narrative
US$24.60
FV
6.0% overvalued
intrinsic discount
-0.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
4 days ago
author updated this narrative
Delek US Holdings
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
Secular Energy Demand And Renewables Will Energize US Refining
Key Takeaways Strong operational execution and efficiency initiatives position Delek for sustained margin expansion and earnings growth, potentially exceeding current expectations. Strategic investments in renewables and logistics diversify revenue streams, de-risk the business, and enhance valuation and margin resilience.
View narrative
US$30.00
FV
27.5% undervalued
intrinsic discount
0.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Vericel
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Expanding Regenerative Therapies Will Open New Market Horizons
Key Takeaways Expanding surgeon network, label extensions, and rising regenerative therapy demand are fueling market penetration, revenue growth, and long-term diversification opportunities. Operational improvements and strong payer acceptance are supporting margin expansion, increased profitability, and stable long-term financial performance.
View narrative
US$53.88
FV
32.7% undervalued
intrinsic discount
23.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
4 days ago
author updated this narrative
Ocular Therapeutix
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts
Aging Global Trends And Novel Delivery Will Expand Markets
Key Takeaways AXPAXLI's unique clinical advantages and potential label claims support premium pricing, durable market share, and strong long-term margin expansion insulated from price competition. Platform innovation and demographic-driven demand growth open multiple recurring revenue streams, reduce business risk, and increase chances of major partnerships or acquisition.
View narrative
US$22.00
FV
42.6% undervalued
intrinsic discount
62.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Altice USA
AN
AnalystHighTarget
Consensus Narrative from 15 Analysts
Accelerated Fiber Expansion Will Spark Premium Broadband Demand
Key Takeaways Accelerated fiber and AI-driven operational gains, along with innovative financing, are positioning the company for significantly stronger revenue and margin performance. Expansion into underpenetrated markets and rapid adoption of premium products are creating new high-margin revenue streams and enhancing long-term growth potential.
View narrative
US$5.37
FV
55.9% undervalued
intrinsic discount
-1.82%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
agilon health
AN
AnalystHighTarget
Consensus Narrative from 14 Analysts
Aging Population And Value-Based Care Will Expand Opportunities
Key Takeaways Strategic focus on higher-value contracts, data analytics, and top-performing partners sets the stage for improved margins and predictable, higher-quality revenue. agilon's value-based care platform, enabled by AI and physician partnerships, is well-positioned for durable growth and market share gains as the industry shifts.
View narrative
US$4.14
FV
73.2% undervalued
intrinsic discount
13.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Arcus Biosciences
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts
Aging Population And Precision Medicine Will Expand Oncology Opportunities
Key Takeaways Lead asset casdatifan and a robust late-stage pipeline position Arcus for rapid market share gains and reduced dependency on any single product. Strong financial backing and strategic partnerships enable accelerated development and sustained innovation, supporting superior margins and future revenue streams.
View narrative
US$47.00
FV
77.9% undervalued
intrinsic discount
13.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Fastly
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Edge Cloud Platforms Will Capture Global Internet Demand
Key Takeaways Multi-year, high-commit contracts and cross-selling are driving durable, high-visibility revenue growth and non-linear margin improvement fueled by new product adoption. Developer-focused platform integration, increasing network efficiency, and disciplined operations are expanding long-term customer value, retention, and operating leverage.
View narrative
US$10.00
FV
30.5% undervalued
intrinsic discount
8.14%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Xencor
AN
AnalystHighTarget
Consensus Narrative from 10 Analysts
Global Aging Trends Will Expand Precision Medicine And Biologics Markets
Key Takeaways XmAb942 and the TL1A x IL-23 bispecific are poised to transform IBD treatment and unlock premium pricing through superior durability, compliance, and dual-pathway efficacy. Xencor's innovative platform, robust pipeline, and rapid clinical execution position it for outsized revenue growth, strategic partnerships, and sustained high-margin royalties.
View narrative
US$40.00
FV
80.8% undervalued
intrinsic discount
32.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Value any company in seconds
Popular companies